Comprehensive study for BRCA1 and BRCA2 entire coding regions in breast cancer
- 25 May 2020
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 23 (1) , 74-81
Abstract
Background About 5–10% of incidences of breast cancers have been reported as a result of germline mutations of BRCA genes. However, the mutational spectrum of BRCA1 and BRCA2 genes among breast cancer Saudi women patients is inadequate at present. Therefore, the present study aimed to report the specific germinal mutation of BRCA1 and BRCA2 in the entire coding regions, to investigate the prevalence rate of BRCA1 & BRCA2 mutations among Saudi women and the effect of these mutations, both benign and malignant tumors. Methodology A total of 270 tissue samples of benign and malignant breast tumors were collected from Saudi women patients, Riyadh, Saudi Arabia. Examination of BRCA1 and BRCA2 germline mutations was performed using heteroduplex DNA analysis (HDA) or single-stranded conformation analysis (SSCA). 177 breast cancer women with malignant tumors and 93 with benign tumors were enrolled in the study. A total of 62 out of 177 breast cancer patients carried a BRCA1 or BRCA2 mutation (54 BRCA1 and 8 BRCA2). The analysis was done using the Sanger sequence assay. Results Point and frameshift mutations through the entire coding area of the two genes indicated that all the mutations were germline alterations and of early-onset breast cancers. The mean ages of diagnosed breast cancer women for BRCA1 and BRCA2 mutation carriers were 36.3 (± 3.5) and 37.9 (± 3.7) years, whereas that of benign control was 35(± 2.5) years. Conclusion Point and frameshift mutations across the entire coding region of BRCA1 and BRCA2 are responsible for many breast cancers cases.Keywords
Funding Information
- Princess Nourah Bint Abdulrahman University (233-ص-38)
This publication has 21 references indexed in Scilit:
- Knowledge, Attitudes and Practices of Breast Cancer Screening Among Women in JordanHealth Care for Women International, 2014
- Hereditary Breast Cancer: Clinical, Pathological and Molecular CharacteristicsBreast Cancer: Basic and Clinical Research, 2014
- BRCA1 and BRCA2mutations in breast cancer patients from VenezuelaBiological Research, 2012
- Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situCancer, 2011
- Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi WomenBreast Cancer Research and Treatment, 2011
- Rapid Detection of Deletion, Insertion, and Substitution Mutations via Heteroduplex Analysis Using Capillary- and Microchip-Based ElectrophoresisGenome Research, 2000
- Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detectionElectrophoresis, 1999
- BRCA1 and BRCA2: from molecular genetics to clinical medicine.Journal of Clinical Oncology, 1998
- BRCA2 mutations in primary breast and ovarian cancersNature Genetics, 1996
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994